Appointed
Scott Kent
Chief Financial Officer
MCFT ·
MasterCraft Boat Holdings, Inc.
Scott Kent, Vice President of Finance, will succeed Mr. Oxley as CFO, effective July 1, 2025.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6851–6900 of 75459
Departed
Timothy M. Oxley
Chief Financial Officer
MCFT ·
MasterCraft Boat Holdings, Inc.
Timothy M. Oxley, Chief Financial Officer (“CFO”) of MasterCraft Boat Holdings, Inc. (the “Company”) announced his resignation as CFO, effective June 30, 2025
Appointed
John T. Treace
Chairman of the Board
TMCI ·
TREACE MEDICAL CONCEPTS, INC.
appoint John T. Treace to serve as Chairman of the Board, effective upon the expiration of James T. Treace’s current term at the Company’s 2025 Annual Meeting.
Departed
James T. Treace
Director
TMCI ·
TREACE MEDICAL CONCEPTS, INC.
his intent to retire from the Board at the expiration of his current term at the 2025 annual meeting of stockholders
Appointed
Steven L. Hoerter
director
MBX ·
MBX Biosciences, Inc.
Effective as of April 7, 2025, the board of directors (the “Board”) of MBX Biosciences, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “NCG Committee”), appointed Steven L. Hoerter as a director of the Company.
Departed
Alan Pickerill
Director
Leafly Holdings, Inc. /DE
Alan Pickerill resigned from the Board of Directors of the Company.
Appointed
Mark S. Finn
director
BBSI ·
BARRETT BUSINESS SERVICES INC
On April 7, 2025, the Board of Directors (the "Board") of Barrett Business Services, Inc. (the "Company") appointed Mark S. Finn, effective April 7, 2025, to serve until the Company's 2025 annual meeting of stockholders, at which time he is expected to stand for re-election.
Departed
Peter A. Scott
Chief Financial Officer
DOC ·
HEALTHPEAK PROPERTIES, INC.
On April 2, 2025, Peter A. Scott informed Healthpeak Properties, Inc. (the “Company”) of his resignation from his position as Chief Financial Officer of the Company.
Departed
Rasesh Patel
Executive Vice President, NRG Consumer
NRG ·
NRG ENERGY, INC.
On April 7, 2025, NRG Energy, Inc. (the “Company”) issued a press release announcing that Rasesh Patel, Executive Vice President, NRG Consumer, has notified the Company of his retirement from the Company, effective May 19, 2025.
Appointed
Darrell Cavens
Director
MTCH ·
Match Group, Inc.
On April 6, 2025, the Board of Directors (the “Board”) of Match Group, Inc. (the “Company”) adopted a resolution appointing Darrell Cavens to the Board
Appointed
Sarbani Chaudhuri
Chief Commercial & Medical Affairs Officer
RCKT ·
ROCKET PHARMACEUTICALS, INC.
On April 7, 2025, Sarbani Chaudhuri was appointed by Rocket Pharmaceuticals, Inc. (the “Company”) as the Company’s Chief Commercial & Medical Affairs Officer.
Departed
(interim)
Kenneth Miller
Chief Commercial Officer
KRMD ·
KORU Medical Systems, Inc.
On April 3, 2025, Kenneth Miller resigned his employment and position as Chief Commercial Officer of KORU Medical Systems, Inc. (the “Company”), effective immediately, to pursue a Chief Executive Officer role at an organization that does not compete with the Company.
Departed
Michael Gibbs
Senior Vice President, General Counsel and Corporate Secretary
T2 Biosystems, Inc.
On March 18, 2025, Michael Gibbs notified the Company of his termination of that certain Consulting Agreement between himself and the Company, dated February 15, 2025 and his resignation from his position as the Company’s Senior Vice President, General Counsel and Corporate Secretary.
Departed
Laura Adams
Director
T2 Biosystems, Inc.
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
John Sperzel
Chief Executive Officer and President
T2 Biosystems, Inc.
On March 31, 2025, John Sperzel notified the Company of his termination of that certain Consulting Agreement between himself and the Company, dated February 15, 2025 and his resignation from his position as the Company’s Chief Executive Officer and President.
Departed
John W. Cumming
Director
T2 Biosystems, Inc.
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
Robin Toft
Director
T2 Biosystems, Inc.
On March 31, 2025, John Sperzel and Robin Toft each notified T2 Biosystems, Inc. (the “Company”) of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately.
Departed
Seymour Liebman
Director
T2 Biosystems, Inc.
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
David Elsbree
Director
T2 Biosystems, Inc.
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed
John Sprague
Chief Financial Officer and Corporate Treasurer
T2 Biosystems, Inc.
On April 3, 2025, John Sprague notified the Company of his resignation from his position as the Company’s Chief Financial Officer and Corporate Treasurer.
Departed
John Sperzel
Director
T2 Biosystems, Inc.
On March 31, 2025, John Sperzel and Robin Toft each notified T2 Biosystems, Inc. (the “Company”) of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately.
Appointed
Craig R. Jalbert
Class I Director
T2 Biosystems, Inc.
On April 3, 2025, the Board appointed Craig R. Jalbert, age 63, as a Class I director and the Company’s Chief Executive Officer, President, Corporate Treasurer, and Corporate Secretary, effective as of 11:30 a.m. on April 3, 2025.
Appointed
Craig R. Jalbert
Chief Executive Officer, President, Corporate Treasurer and Corporate Secretary
T2 Biosystems, Inc.
On April 3, 2025, the Board appointed Craig R. Jalbert, age 63, as a Class I director and the Company’s Chief Executive Officer, President, Corporate Treasurer, and Corporate Secretary, effective as of 11:30 a.m. on April 3, 2025.
Appointed
Jeff Ajer
Director
VRDN ·
Viridian Therapeutics, Inc.\DE
On April 2, 2025, the Board of Directors (the “Board”) of Viridian Therapeutics, Inc. (the “Company”), appointed Jeff Ajer to serve as a Class I director of the Company, effective as of April 7, 2025.
Appointed
(interim)
Christina L. Zamarro
Executive Vice President and Chief Financial Officer
GT ·
GOODYEAR TIRE & RUBBER CO /OH/
Ms. Christina L. Zamarro, Executive Vice President and Chief Financial Officer of the Company, will lead the EMEA business unit on an interim basis in addition to her duties as Chief Financial Officer.
Departed
Christopher R. Delaney
President, Europe, Middle East and Africa
GT ·
GOODYEAR TIRE & RUBBER CO /OH/
Effective April 4, 2025, Christopher R. Delaney, President, Europe, Middle East and Africa (“EMEA”), is on a leave of absence from his position with The Goodyear Tire & Rubber Company (the “Company”).
Appointed
John Berisford
Director
CSGP ·
COSTAR GROUP, INC.
Effective as of April 6, 2025, the Board elected each of Christine M. McCarthy, John Berisford and Rachel C. Glaser to serve on the Board.
Appointed
Rachel C. Glaser
Director
CSGP ·
COSTAR GROUP, INC.
Effective as of April 6, 2025, the Board elected each of Christine M. McCarthy, John Berisford and Rachel C. Glaser to serve on the Board.
Appointed
Christine M. McCarthy
Director
CSGP ·
COSTAR GROUP, INC.
Effective as of April 6, 2025, the Board elected each of Christine M. McCarthy, John Berisford and Rachel C. Glaser to serve on the Board.
Departed
Michael R. Klein
Director
CSGP ·
COSTAR GROUP, INC.
Effective as of April 6, 2025, each of Michael R. Klein, Christopher J. Nassetta and Laura C. Kaplan tendered their resignations from the Board, all applicable Board committees and, for Mr. Klein, from his role as Chairman of the Board, effective as of the election of the New Independent Appointees.
Departed
Laura C. Kaplan
Director
CSGP ·
COSTAR GROUP, INC.
Effective as of April 6, 2025, each of Michael R. Klein, Christopher J. Nassetta and Laura C. Kaplan tendered their resignations from the Board, all applicable Board committees and, for Mr. Klein, from his role as Chairman of the Board, effective as of the election of the New Independent Appointees.
Departed
Christopher J. Nassetta
Director
CSGP ·
COSTAR GROUP, INC.
Effective as of April 6, 2025, each of Michael R. Klein, Christopher J. Nassetta and Laura C. Kaplan tendered their resignations from the Board, all applicable Board committees and, for Mr. Klein, from his role as Chairman of the Board, effective as of the election of the New Independent Appointees.
Departed
Rodney Adkins
Director
PYPL ·
PayPal Holdings, Inc.
On April 4, 2025, Rodney Adkins informed PayPal Holdings, Inc. (“PayPal” or the “Company”) that he will not stand for re-election to PayPal’s Board of Directors (“Board”) when his current term expires at PayPal’s 2025 Annual Meeting of Stockholders (“2025 Annual Meeting”).
Appointed
Virginia L. Grebbien
Director
BWMN ·
Bowman Consulting Group Ltd.
On April 3, 2025, the board of directors (the “Board”) of Bowman Consulting Group Ltd. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Virginia L. Grebbien to serve as a Class II director, effective as of such date
Appointed
Martin Sjolund
President and Chief Executive Officer
PRAA ·
PRA GROUP INC
On April 2, 2025, the Board appointed Martin Sjolund to succeed Mr. Atal as the Company’s President and Chief Executive Officer, effective on June 17, 2025, immediately following the 2025 Annual Meeting.
Departed
Glenn P. Marino
Director
PRAA ·
PRA GROUP INC
In addition, on April 2, 2025, Glenn P. Marino notified the Company of his decision to retire from the Board immediately following the 2025 Annual Meeting.
Departed
Vikram A. Atal
President and Chief Executive Officer
PRAA ·
PRA GROUP INC
On April 2, 2025, Vikram A. Atal, President and Chief Executive Officer of PRA Group, Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) of his decision to retire as President and Chief Executive Officer and as a member of the Board, effective on June 17, 2025, immediately following the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
Departed
Scott D. Deverell
Corporate Controller and Principal Accounting Officer
TRNS ·
TRANSCAT INC
On April 1, 2025, Scott D. Deverell notified Transcat, Inc. (the “Company”) of his intention to retire from his position as Corporate Controller and Principal Accounting Officer of the Company.
Departed
David Lazar
President
YHC ·
LQR House Inc.
On April 2, 2025, David Lazar resigned as President and as member of the Board of Directors (the “Board”) of the Company, with such resignation becoming effective April 2, 2025
Appointed
Steve Salis
Director
SZZL ·
Sizzle Acquisition Corp. II
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Appointed
Jamie Karson
Director
SZZL ·
Sizzle Acquisition Corp. II
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Appointed
Warren Thompson
Director
SZZL ·
Sizzle Acquisition Corp. II
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Appointed
David Perlin
Director
SZZL ·
Sizzle Acquisition Corp. II
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Appointed
Neil Leibman
Director
SZZL ·
Sizzle Acquisition Corp. II
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Appointed
Joseph Onorati
Director
DFDV ·
DeFi Development Corp.
On April 4, 2025, the Board elected each of Joseph Onorati, Marco Santori and Zachary Tai as directors of the Company, to fill the vacancies on the Board.
Departed
Ned Siegel
Director
DFDV ·
DeFi Development Corp.
Effective as of April 4, 2025, Samuel Haskell, Marcelo Lemos and Ned Siegel resigned from the Board and, to the extent applicable, all committees thereof.
Appointed
Joseph Onorati
Chief Executive Officer
DFDV ·
DeFi Development Corp.
- Mr. Onorati was appointed by the Board as the chief executive officer of the Company.
Role change
Blake Janover
Chief Commercial Officer
DFDV ·
DeFi Development Corp.
- Blake Janover, former CEO of the Company, was appointed by the Board as the chief commercial officer of the Company.
Departed
Marcelo Lemos
Director
DFDV ·
DeFi Development Corp.
Effective as of April 4, 2025, Samuel Haskell, Marcelo Lemos and Ned Siegel resigned from the Board and, to the extent applicable, all committees thereof.
Appointed
Zachary Tai
Director
DFDV ·
DeFi Development Corp.
On April 4, 2025, the Board elected each of Joseph Onorati, Marco Santori and Zachary Tai as directors of the Company, to fill the vacancies on the Board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.